F, G., A, T., Z, O., S, S., RA, G., P, M., . . . F, H. (2025). GLP1 receptor agonists and SGLT2 inhibitors for the prevention or delay of type 2 diabetes mellitus onset: A systematic review and meta-analysis. Frontiers in endocrinology, 16, 1627909. https://doi.org/10.3389/fendo.2025.1627909
Chicago Style (17th ed.) CitationF, Ghobar, et al. "GLP1 Receptor Agonists and SGLT2 Inhibitors for the Prevention or Delay of Type 2 Diabetes Mellitus Onset: A Systematic Review and Meta-analysis." Frontiers in Endocrinology 16 (2025): 1627909. https://doi.org/10.3389/fendo.2025.1627909.
MLA (9th ed.) CitationF, Ghobar, et al. "GLP1 Receptor Agonists and SGLT2 Inhibitors for the Prevention or Delay of Type 2 Diabetes Mellitus Onset: A Systematic Review and Meta-analysis." Frontiers in Endocrinology, vol. 16, 2025, p. 1627909, https://doi.org/10.3389/fendo.2025.1627909.